CUePEAK Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 8

CUePEAK Bio General Information

Description

Developer of atopic dermatitis designed for the treatment of skin disease. The company discovers and develops drugs for multiple uses by synthesizing a compound based on Acylhydrazone, enabling patients with treatment for various skin diseases and skin cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 301, 302, Bio Venture Center (BVC)
  • Korea Research Institute of Bioscience and Biotechnology, 125, Gwahak-ro, Yuseong-gu
  • Daejeon, 34141
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Vertical(s)
Corporate Office
  • Room 301, 302, Bio Venture Center (BVC)
  • Korea Research Institute of Bioscience and Biotechnology, 125, Gwahak-ro, Yuseong-gu
  • Daejeon, 34141
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CUePEAK Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 20-Feb-2024 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Accelerator/Incubator Completed Generating Revenue
2. Debt - General 01-Apr-2021 $353K $763K Completed Generating Revenue
1. Seed Round 19-Jun-2020 $410K $410K Completed Generating Revenue
To view CUePEAK Bio’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

CUePEAK Bio Patents

CUePEAK Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4837576-A1 Composition comprising tubulin inhibitor for preventing or treating skin diseases Pending 06-Jan-2025
EP-4837581-A1 Composition comprising tubulin inhibitor for preventing or treating skin diseases Pending 06-Jan-2025
WO-2025147178-A1 Composition comprising tubulin inhibitor for preventing or treating skin diseases Inactive 05-Jan-2024
WO-2025147180-A1 Composition comprising tubulin inhibitor for preventing or treating skin diseases Inactive 05-Jan-2024
WO-2025147181-A1 Composition for preventing or treating hair loss comprising tubulin inhibitor Inactive 05-Jan-2024 A61K31/44
To view CUePEAK Bio’s complete patent history, request access »

CUePEAK Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CUePEAK Bio Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Rising S Ventures Venture Capital Minority
Bluepoint Venture Capital Minority
Capstone Partners Investment Bank Minority
Capstone Partners Korea Venture Capital Minority
Korea Technology Finance Government Minority
You’re viewing 5 of 8 investors. Get the full list »

CUePEAK Bio FAQs

  • When was CUePEAK Bio founded?

    CUePEAK Bio was founded in 2020.

  • Where is CUePEAK Bio headquartered?

    CUePEAK Bio is headquartered in Daejeon, South Korea.

  • What is the size of CUePEAK Bio?

    CUePEAK Bio has 4 total employees.

  • What industry is CUePEAK Bio in?

    CUePEAK Bio’s primary industry is Drug Discovery.

  • Is CUePEAK Bio a private or public company?

    CUePEAK Bio is a Private company.

  • What is CUePEAK Bio’s current revenue?

    The current revenue for CUePEAK Bio is .

  • How much funding has CUePEAK Bio raised over time?

    CUePEAK Bio has raised $763K.

  • Who are CUePEAK Bio’s investors?

    Rising S Ventures, Bluepoint, Capstone Partners, Capstone Partners Korea, and Korea Technology Finance are 5 of 8 investors who have invested in CUePEAK Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process